• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number SET W/ QUADROX OPEN/CLOSED
Device Problems Partial Blockage (1065); Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/04/2019
Event Type  malfunction  
Manufacturer Narrative
A follow-up medwatch will be submitted when additional information becomes available.
 
Event Description
''oxys were used in an operation and have poor oxygenation.'' customer complaint number: (b)(4).
 
Event Description
Complaint # (b)(4).
 
Manufacturer Narrative
The complained products were requested for the sample investigation.Two oxygenators (hqv 0737 # hlm - set mod.Tübingen cormed) were delivered as complaint samples.The oxygenators were cleaned with sodium hypochlorite and disinfected with incidin liquid.Visual inspection and a leak test according to local procedure lv 201 (blood side) were performed.During the leak test , a leak was found at the hose connection, at the blood inlet connector of the oxygenator 1.Also, it was found that the oxygenator 2 was damaged (cracked).No damage or leakage was reported from the customer.The found damages may have occurred during the shipment of the product to the maquet cardiopulmonary laboratory.No pressure abnormalities were found in the function test using a roller pump.Trend search was performed and no systemic issue could be found.Device history record review for complaint (b)(4) and lot 70129356 was performed.There were no references found which are indicating a nonconformance of the product in question.The device was manufactured in compliance with defined production steps and specifications.Appropriate manufacturing documentation and production step controls were in place.Therefore no manufacturing problem was detected.The reported failure was identified as part of the current risk management file (dms #1464420 v15)mitigations for this specific failure are in place as per design specifications and in instruction for use.Mitigation-112/ instruction for use: a pressure drop on the oxygenator can be a sign of reduced performance.This can lead to inadequate patient support monitor the pressure drop by measuring the pressure upstream and downstream of the oxygenator.Consider replacing the oxygenator if the pressure drop is significant.Check the gas exchange rate using blood gas analyses.Prepare to replace the oxygenator.Mitigation-061/ design.The surfaces of the quadrox-i-id small adult / adult with blood contact shall consist of hemocompatible material according to din en iso 10993-4.In order to investigate the issue and identify any product problem, relevant questions were asked.The perfusion protocol and the available information has been shared internally with getinge therapy application manager.It was stated that " the heparin administration was done because of a hospital standard related on time (the whole case was 5h).If the lowest heparin dose according to standard was given initially (300iu/kg) and 10000iu have been in the priming, 31600iu were active in the circulating blood.The halftime of heparin is 90min.So the measured act does not correlate with the amount of heparin circulating in the blood over the whole time of the perfusion.The anti-thrombin value is unknown.'' because of lack of information, it can not be fully determined whether it is user related.Therefore the claim by the clinic that the device has caused oxygenating problems cannot be nullified.The failure could be confirmed.However, the exact cause of the failure could not be identified.The reported failure did not contribute to death or serious injury.In addition at this time it cannot be concluded that this is a systemic error.Thus, no remedial action is required.No corrective actions are required.This complaint is being monitored as part of the complaint data trending of maquet cardiopulmonary gmbh and further investigations and measures will be conducted in case of adverse trending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key9438814
MDR Text Key169920361
Report Number8010762-2019-00375
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K132829
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSET W/ QUADROX OPEN/CLOSED
Device Catalogue Number70106.5907
Device Lot Number70129356
Date Manufacturer Received07/01/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
-
-